Holen Sie sich die Stockscreener-App
5.56
4.32%
0.23
Schlusskurs vom Vortag:
$5.33
Offen:
$5.44
24-Stunden-Volumen:
4.72M
Relative Volume:
1.15
Marktkapitalisierung:
$1.94B
Einnahmen:
$143.05M
Nettoeinkommen (Verlust:
$-145.99M
KGV:
-12.98
EPS:
-0.4282
Netto-Cashflow:
$-134.06M
1W Leistung:
+16.81%
1M Leistung:
+32.07%
6M Leistung:
-38.15%
1J Leistung:
+210.61%
1-Tages-Spanne:
$5.33
$5.575
1-Wochen-Bereich:
$4.86
$5.575
52-Wochen-Spanne:
$1.81
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
Firmenname
Nuvation Bio Inc
Sektor
Branche
Telefon
332-208-6102
Adresse
1500 BROADWAY, NEW YORK
Compare NUVB vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
5.56 | 1.94B | 143.05M | -145.99M | -134.06M | -0.4282 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-19 | Eingeleitet | B. Riley Securities | Buy |
| 2025-09-30 | Eingeleitet | Jefferies | Buy |
| 2025-04-23 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Hochstufung | Jefferies | Hold → Buy |
| 2024-03-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-02 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-04-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-03-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-03-08 | Eingeleitet | BTIG Research | Buy |
| 2021-03-08 | Eingeleitet | Cowen | Outperform |
| 2021-03-08 | Eingeleitet | Jefferies | Buy |
| 2021-03-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
Nuvation Bio (NYSE:NUVB) Leads Biotech Penny Watch - Kalkine Media
Nuvation Bio Inc (NUVB) Institutional Confidence - TradingKey
Nuvation Bio Inc (NUVB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Nuvation Bio Inc (NUVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nuvation Bio Inc (NUVB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nuvation Bio Inc (NUVB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum - AOL.com
Nuvation Bio Inc (NUVB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuvation Bio Inc (NUVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvation Bio Inc (NUVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum - The Motley Fool
Nuvation Bio Inc (NUVB_t) Institutional Confidence - TradingKey
Nuvation Bio Inc (NUVB_t) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nuvation Bio Inc (NUVB_t) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nuvation Bio Inc (NUVB_t) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Nuvation Bio Is Turning Heads As A Biotech Penny Stock? - Kalkine Media
Here’s What the Acquisition of Nuvalent Means for Nuvation Bio (NUVB) - Insider Monkey
Why Is Nuvation Bio Back On Penny Stock Watchlists? - Kalkine Media
5 Best Penny Stocks That Could Skyrocket in 2026 - Insider Monkey
Nuvation Bio: David Hung's Latest Venture Looks Undervalued At Current Level (NYSE:NUVB) - Seeking Alpha
Nuvation Bio director Robert Mashal buys $118,250 in stock - Investing.com
Nuvation Bio (NUVB) director’s trust buys 25,000 Class A shares - Stock Titan
Nuvation Bio stock reiterated at Market Outperform by Citizens - Investing.com India
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating - Moomoo
Spotlight On Promising Penny Stocks For June 2026 - simplywall.st
Nuvation Bio stock reiterated at Market Outperform by Citizens By Investing.com - Investing.com Australia
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value By Investing.com - Investing.com Australia
RBC Capital reiterates Nuvation Bio stock rating on ROS1 space value - Investing.com Nigeria
Nuvation Bio: Buy The Ibtrozi Launch (Rating Upgrade) (NYSE:NUVB) - Seeking Alpha
Nuvation Bio (NUVB) Presents Outcomes from TRUST-II Study - Insider Monkey
Nuvation Bio’s cancer drug sNDA accepted by FDA for review - Investing.com
5 Best Penny Stocks with Huge Upside Potential - Insider Monkey
A Look At Nuvation Bio (NUVB) Valuation After New IBTROZI Outcomes And Regulatory Progress - simplywall.st
RBC Capital raises Nuvation Bio stock price target on glioma potential - Investing.com
NUVB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NUVB Stock Price, Quote & Chart | NUVATION BIO INC (NYSE:NUVB) - ChartMill
NUVB Q1 2026 Earnings: Modest EPS Beat Amid Continued Clinical ProgressEarnings Stability Report - newsline.com
Nuvation Bio Inc. Files Form 8-K with SEC Detailing Company Information and Annual Meeting Results - Minichart
Best Stocks Under $15 to Buy Right Now for High Growth Potential - Analytics Insight
Nuvation Bio execs to speak at Jefferies Healthcare Conference on June 3, 2026 - Pluang
Nuvation Bio to Present at the Jefferies Global Healthcare Conference - Investing News Network
Nuvation Bio (NUVB) shareholders elect directors, ratify KPMG and approve pay - Stock Titan
Nuvation Bio (NUVB) Reveals Promising Data from TRUST-II Study - GuruFocus
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - Investing News Network
Nuvation Bio presents quality of life data for IBTROZI at ASCO - Investing.com Nigeria
Nuvation Bio presents quality of life data for IBTROZI at ASCO By Investing.com - Investing.com South Africa
Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting - PR Newswire
Nuvation Bio Inc. (NUVB) director awarded 76,923 stock options in corrected filing - Stock Titan
Nuvation Bio (NASDAQ: NUVB) awards 123,397 stock options to director - Stock Titan
Nuvation Bio (NUVB) director gets 123,397 stock options at $4.79 - Stock Titan
Director at Nuvation Bio (NASDAQ: NUVB) awarded 123,397 stock options - Stock Titan
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):